Immediate Impact

73 standout
Sub-graph 1 of 23

Citing Papers

Targeting and engineering long non-coding RNAs for cancer therapy
2024 Standout
Oxidative cell death in cancer: mechanisms and therapeutic opportunities
2024 Standout
2 intermediate papers

Works of Libin Zou being referenced

LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer
2021
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer
2020

Author Peers

Author Last Decade Papers Cites
Libin Zou 213 182 110 12 291
Junqi Luo 240 209 113 9 333
Zhou Yang 197 164 96 12 297
Yarui Ma 171 94 98 10 259
Jinchun Xing 215 140 113 14 298
Chengwu Gong 211 165 93 12 306
Feng Ye 217 170 99 8 308
Changying Jing 182 142 122 11 286
Yuwei Wang 162 77 87 12 296
Tianyu Qu 200 109 44 16 269
Le Tang 179 187 59 12 274

All Works

Loading papers...

Rankless by CCL
2026